List of Figures
Figure 1: Osteoporosis Therapeutics Market, Treatment Algorithm of Osteoporosis 22
Figure 2: Osteoporosis Therapeutics Market, Comparative Efficacy and Safety Heat Map for Marketed Products for the Treatment of Osteoporosis 41
Figure 3: Osteoporosis Therapeutics Market, Comparative Efficacy Heat Map for Marketed Products for the Treatment of Osteoporosis in Men 41
Figure 4: Osteoporosis Therapeutics Market, Comparative Efficacy Heat Map for Marketed Products for the Treatment of Glucocorticoid-Induced Osteoporosis 42
Figure 5: Osteoporosis Therapeutics Market, Comparative Efficacy Heat Map for Marketed Products for the Prevention of Osteoporosis in Postmenopausal Women 42
Figure 6: Pipeline for Osteoporosis Therapeutics, Global, 2016 45
Figure 7: Pipeline for Osteoporosis Therapeutics by Molecular Target, Global, 2016 48
Figure 8: Pipeline for Osteoporosis Therapeutics by Molecular Target and Stage of Development, Global, 2016 49
Figure 9: Osteoporosis Therapeutics Market, Asia-Pacific, Romosozumab Market Forecast ($m), 2018–2022 52
Figure 10: Osteoporosis Therapeutics Market, Asia-Pacific, Abaloparatide Market Forecast ($m), 2018–2022 55
Figure 11: Osteoporosis Therapeutics Market, Asia-Pacific, Odanacatib Market Forecast ($m), 2018–2022 57
Figure 12: Osteoporosis Therapeutics Market, Asia-Pacific, Uni-PTH Market Forecast ($m), 2020–2021 59
Figure 13: Osteoporosis Therapeutics Market, Comparative Efficacy Heat Map for Pipeline Products 60
Figure 14: Osteoporosis Therapeutics Market, Global, Competitor Matrix for Marketed and Pipeline Products, 2016 61
Figure 15: Osteoporosis Therapeutics, Global, Average Clinical Trial Failure Rate (%), 2006–2015 63
Figure 16: Osteoporosis Therapeutics, Global, Clinical Trial Failure Rates by Molecule Type (%), 2006–2015 64
Figure 17: Osteoporosis Therapeutics, Global, Clinical Trial Failure Rates by Molecular Target (%), 2006–2015 65
Figure 18: Osteoporosis Therapeutics, Global, Clinical Trial Duration by Molecule Type, 2006–2015 66
Figure 19: Osteoporosis Therapeutics, Global, Clinical Trial Duration by Molecular Target, 2006–2015 68
Figure 20: Osteoporosis Therapeutics, Global, Clinical Trial Size per Product by Molecule Type, 2006–2015 69
Figure 21: Osteoporosis Therapeutics, Global, Clinical Trial Size per Product by Molecular Target, 2006–2015 70
Figure 22: Osteoporosis Therapeutics, Global, Clinical Trial Size per Trial by Molecule Type, 2006–2015 71
Figure 23: Osteoporosis Therapeutics, Global, Clinical Trial Size per Trial by Molecular Target, 2006–2015 72
Figure 24: Osteoporosis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 73
Figure 25: Osteoporosis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 73
Figure 26: Osteoporosis Therapeutics Market, Asia-Pacific, Treatment Patterns (million) and Market Size ($bn), 2015–2022 75
Figure 27: Osteoporosis Therapeutics Market, India, Treatment Patterns (million), 2015–2022 77
Figure 28: Osteoporosis Therapeutics Market, India, Annual Cost of Therapy ($), 2015–2022 78
Figure 29: Osteoporosis Therapeutics Market, India, Market Size ($m), 2015–2022 79
Figure 30: Osteoporosis Therapeutics Market, China, Treatment Patterns (million), 2015–2022 80
Figure 31: Osteoporosis Therapeutics Market, China, Annual Cost of Therapy ($), 2015–2022 81
Figure 32: Osteoporosis Therapeutics Market, China, Market Size ($m), 2015–2022 82
Figure 33: Osteoporosis Therapeutics Market, Australia, Treatment Patterns (‘000), 2015–2022 83
Figure 34: Osteoporosis Therapeutics Market, Australia, Annual Cost of Therapy ($), 2015–2022 85
Figure 35: Osteoporosis Therapeutics Market, Australia, Market Size ($m), 2015–2022 86
Figure 36: Osteoporosis Therapeutics Market, South Korea, Treatment Patterns (‘000), 2015–2022 87
Figure 37: Osteoporosis Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2015–2022 88
Figure 38: Osteoporosis Therapeutics Market, South Korea, Market Size ($m), 2015–2022 89
Figure 39: Osteoporosis Therapeutics Market, Japan, Treatment Patterns (million), 2015–2022 90
Figure 40: Osteoporosis Therapeutics Market, Japan, Annual Cost of Therapy ($), 2015–2022 91
Figure 41: Osteoporosis Therapeutics Market, Japan, Market Size ($m), 2015–2022 92
Figure 42: Osteoporosis Therapeutics Market, Global, Licensing Deals by Region and Value, 2006–2015 96
Figure 43: Osteoporosis Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2006–2015 97
Figure 44: Osteoporosis Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value and Upfront Payment Value, 2006–2015 98
Figure 45: Osteoporosis Therapeutics Market, Global, Licensing Deals by Molecule Type and Stage of Development, 2006–2015 99
Figure 46: Osteoporosis Therapeutics Market, Global, Licensing Deals by Molecular Targets and Aggregate Deal Value ($), 2006–2015 100
Figure 47: Osteoporosis Therapeutics Market, Global, Co-development Deals by Region, 2006–2015 102
Figure 48: Osteoporosis Therapeutics Market, Global, Number of Disclosed and Undisclosed Co-development Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2006–2015 103
Figure 49: Osteoporosis Therapeutics Market, Global, Co-development Deals by Molecule Type and Stage of Development, 2006–2015 104
Figure 50: Osteoporosis Therapeutics Market, Global, Co-development Deals by Molecular Target, 2006–2015 104